Literature DB >> 17463076

Health, disability, and life insurance experiences of working-age persons with multiple sclerosis.

L I Iezzoni1, L Ngo.   

Abstract

Working-age Americans with multiple sclerosis (MS) may face considerable financial insecurities when they become unable to work and lack the health, disability, and life insurance typically offered through employers. In order to estimate the rates of having these insurance policies, as well as how insurance status affects reports of financial stress, we conducted half-hour telephone interviews with 983 working-age persons across the US, who reported being diagnosed with MS. The interviews occurred from May through November 2005, and among the sampled individuals contacted and confirmed eligible, 93.2% completed the interview. The study population was largely female (78.9%), Caucasian (86.4%), married (68.6%), with at least some college education (71.5%), and unemployed (60.2%). Overall, 96.3% had some health insurance (40.3% with public health insurance, primarily Medicare), 56.7% had long-term disability insurance (36.4% with public programs), and 68.3% had life insurance. Notably, 27.4% indicated that, since being diagnosed with MS, health insurance concerns had significantly affected employment decisions. In addition, 16.4% reported considerable difficulty paying for health care, 27.4% put off or postponed seeking needed health care because of costs, and 22.3% delayed filling prescriptions, skipped medication doses, or split pills because of costs. Overall, 26.6% reported considerable worries about affording even basic necessities, such as food, utilities, and housing.

Entities:  

Mesh:

Year:  2007        PMID: 17463076     DOI: 10.1177/1352458506071356

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study.

Authors:  Elodie J O'Connor; Marita P McCabe
Journal:  Qual Life Res       Date:  2010-12-02       Impact factor: 4.147

2.  The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.

Authors:  Jasmina I Ivanova; Howard G Birnbaum; Seth Samuels; Matthew Davis; Amy L Phillips; Dennis Meletiche
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Informal caregivers assisting people with multiple sclerosis: factors associated with the strength of the caregiver/care recipient relationship.

Authors:  Robert J Buchanan; Chunfeng Huang
Journal:  Int J MS Care       Date:  2011

Review 4.  Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors:  Daniel M Hartung
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

5.  Change in perceived health insurance coverage among people with multiple sclerosis.

Authors:  Alyssa Pozniak; Louise Hadden; William Rhodes; Sarah Minden
Journal:  Int J MS Care       Date:  2014

6.  The development of ICF Core Sets for multiple sclerosis: results of the International Consensus Conference.

Authors:  Michaela Coenen; Alarcos Cieza; Jenny Freeman; Fary Khan; Deborah Miller; Andrea Weise; Jürg Kesselring
Journal:  J Neurol       Date:  2011-03-04       Impact factor: 4.849

7.  Assessing Access to Five Types of Insurance by People with Multiple Sclerosis Using a Cross-sectional Online Survey.

Authors:  Deborah M Miller; Stacey S Cofield; Sarah M Planchon; Sarah E Givens; Amber Salter; Hollie K Schmidt; Sabrina Corlette; Carol C Musil
Journal:  Int J MS Care       Date:  2021-08-18

8.  Health care worry is associated with worse outcomes in multiple sclerosis.

Authors:  Salene M Jones; Dagmar Amtmann
Journal:  Rehabil Psychol       Date:  2014-07-14

9.  Incorporation and Impact of a Clinical Pharmacist in a Hospital-Based Neurology Clinic Treating Patients with Multiple Sclerosis.

Authors:  Alexandria May; Olivia Morgan; Kristi Quairoli
Journal:  Int J MS Care       Date:  2020-02-14

10.  Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018.

Authors:  Zizi Elsisi; Ana L Hincapie; Jeff Jianfei Guo
Journal:  Am Health Drug Benefits       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.